These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35872290)
1. Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-κB signaling pathway in rats with pulmonary arterial hypertension. Chen T; Su S; Yang Z; Zhang D; Li Z; Lu D J Ethnopharmacol; 2022 Oct; 297():115572. PubMed ID: 35872290 [TBL] [Abstract][Full Text] [Related]
2. Srolo Bzhtang, a traditional Tibetan medicine formula, inhibits cigarette smoke induced airway inflammation and muc5ac hypersecretion via suppressing IL-13/STAT6 signaling pathway in rats. Jing L; Su S; Zhang D; Li Z; Lu D; Ge R J Ethnopharmacol; 2019 May; 235():424-434. PubMed ID: 30731182 [TBL] [Abstract][Full Text] [Related]
3. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats. Shi R; Wei Z; Zhu D; Fu N; Wang C; Yin S; Liang Y; Xing J; Wang X; Wang Y Pulm Pharmacol Ther; 2018 Feb; 48():124-135. PubMed ID: 29133079 [TBL] [Abstract][Full Text] [Related]
4. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling. Liu J; Fang G; Lan C; Qiu C; Yao L; Zhang Q; Hu J; Zhang Y; Yang Y; Zhang Y Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631 [TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways. Yu M; Wu X; Wang J; He M; Han H; Hu S; Xu J; Yang M; Tan Q; Wang Y; Wang H; Xie W; Kong H Int J Med Sci; 2022; 19(4):681-694. PubMed ID: 35582418 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation. Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628 [TBL] [Abstract][Full Text] [Related]
8. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation. Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823 [TBL] [Abstract][Full Text] [Related]
9. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats. Tang C; Luo Y; Li S; Huang B; Xu S; Li L Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977 [TBL] [Abstract][Full Text] [Related]
11. 18β-Glycyrrhetinic acid ameliorates endoplasmic reticulum stress-induced inflammation in pulmonary arterial hypertension through PERK/eIF2α/NF-κB signaling. Wang JL; Liu H; Jing ZC; Zhao F; Zhou R Chin J Physiol; 2022; 65(4):187-198. PubMed ID: 36073567 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats. Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584 [TBL] [Abstract][Full Text] [Related]
13. Hepcidin protects pulmonary artery hypertension in rats by activating NF-κB/TNF-α pathway. Liu WY; Wang L; Lai YF Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7573-7581. PubMed ID: 31539149 [TBL] [Abstract][Full Text] [Related]
14. The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB. Bai Y; Li ZX; Wang HL; Lian GC; Wang Y Int J Mol Med; 2017 Jul; 40(1):155-163. PubMed ID: 28560440 [TBL] [Abstract][Full Text] [Related]
15. Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways. Chen Y; Li H; Li M; Niu S; Wang J; Shao H; Li T; Wang H J Ethnopharmacol; 2017 Mar; 200():165-173. PubMed ID: 28232127 [TBL] [Abstract][Full Text] [Related]
16. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension. Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861 [TBL] [Abstract][Full Text] [Related]
17. Monocrotaline-induced pulmonary arterial hypertension is attenuated by TNF-α antagonists via the suppression of TNF-α expression and NF-κB pathway in rats. Wang Q; Zuo XR; Wang YY; Xie WP; Wang H; Zhang M Vascul Pharmacol; 2013 Jan; 58(1-2):71-7. PubMed ID: 22846229 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of coptisine free base in mice through inhibition of NF-κB and MAPK signaling pathways. Chen HB; Luo CD; Liang JL; Zhang ZB; Lin GS; Wu JZ; Li CL; Tan LH; Yang XB; Su ZR; Xie JH; Zeng HF Eur J Pharmacol; 2017 Sep; 811():222-231. PubMed ID: 28648405 [TBL] [Abstract][Full Text] [Related]
19. Grape seed proanthocyanidin inhibits monocrotaline-induced pulmonary arterial hypertension via attenuating inflammation: in vivo and in vitro studies. Chen F; Wang H; Zhao J; Yan J; Meng H; Zhan H; Chen L; Yuan L J Nutr Biochem; 2019 May; 67():72-77. PubMed ID: 30856466 [TBL] [Abstract][Full Text] [Related]